InvestorsHub Logo
icon url

Diamondjim61

05/28/20 7:27 AM

#285510 RE: antihama #285509

The stock already doubled. A master of the obvious.
icon url

longfellow95

05/28/20 7:33 AM

#285511 RE: antihama #285509

Think this guy did previous with a negative slant.
So now he is hedging his bets a bit.
But he still perpetuates the fallacy that the trial was 'halted' for 2yrs:-

To further complicate the matter, in 2015, the Food and Drug Administration halted DCVax-L's clinical trial.


And he gives this baloney:-

Even with a potential survival head start compared to other clinical trials due to a screening criterion requiring patients to be progression-free before enrollment, patients' survival in the two cohorts of DCVax-L's clinical trial compares very favorably to historical rates.


What is he talking about? All these ndGBM trials require subjects to be progression free at the time of enrolment.
icon url

KIPK

05/28/20 7:50 AM

#285518 RE: antihama #285509

Anything Out Of Motley Fool NOT WORTH Paying Attention To..

Their Whole Strategy Is To High Light A Given COMPANY/////

And Then, Regardless Of What The Company Under Discussion Does Or Does Not, Pumping Companies That Are Listed Under Their Client Subscription Package....

Worse among Bad Pay Per Investment Ideas Companies...
icon url

learningcurve2020

05/28/20 9:00 AM

#285535 RE: antihama #285509

14 years! How much in salaries is that?

“Well, this is good news because investors have been waiting for 14 years for that announcement. “